Hoppa till innehållet

OMXSPI+0,50%

S&P 500+0,80%

FTSE 100+0,54%

DAX+0,01%

NIKKEI+0,94%
Redeye: AVTECH - Clear path for continued growth

Redeye states that the report aligned with preliminary figures and showed net sales in line with estimates, but EBITDA was slightly below Redeye’s expectations. The EBITDA ‘miss’ is related to ‘elevated’ OPEX, which we expect to remain as AVTECH plans on significant investments during 2024 to expand its product portfolio. Redeye sees short-term catalysts as it expects a few legacy carriers to conclude trials during Q1 2024. Redeye raised its fair value range.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

AVTECH - Clear path for continued growth

Source:MFN
Tillbaka

Det verkar som att du använder en annonsblockerare

Om du är prenumerant behöver du logga in för att fortsätta. Vill du bli prenumerant kan du läsa Di Digitalt för 197 kr inkl. moms de första 3 månaderna.

spara
1180kr
Prenumerera